EA201070715A1 - Режимы дозирования, фармацевтические композиции и упаковки для экстренной контрацепции - Google Patents

Режимы дозирования, фармацевтические композиции и упаковки для экстренной контрацепции

Info

Publication number
EA201070715A1
EA201070715A1 EA201070715A EA201070715A EA201070715A1 EA 201070715 A1 EA201070715 A1 EA 201070715A1 EA 201070715 A EA201070715 A EA 201070715A EA 201070715 A EA201070715 A EA 201070715A EA 201070715 A1 EA201070715 A1 EA 201070715A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical compositions
packages
emergency contraception
dosing modes
dosing
Prior art date
Application number
EA201070715A
Other languages
English (en)
Russian (ru)
Inventor
Чарльз И. Дилиберти
Original Assignee
Тева Вимен'С Хелс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тева Вимен'С Хелс, Инк. filed Critical Тева Вимен'С Хелс, Инк.
Publication of EA201070715A1 publication Critical patent/EA201070715A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EA201070715A 2007-12-20 2008-12-19 Режимы дозирования, фармацевтические композиции и упаковки для экстренной контрацепции EA201070715A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US828707P 2007-12-20 2007-12-20
PCT/US2008/013933 WO2009082478A1 (en) 2007-12-20 2008-12-19 Dosage regimens and pharmaceutical compositions and packages for emergency contraception

Publications (1)

Publication Number Publication Date
EA201070715A1 true EA201070715A1 (ru) 2011-02-28

Family

ID=40799234

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201070715A EA201070715A1 (ru) 2007-12-20 2008-12-19 Режимы дозирования, фармацевтические композиции и упаковки для экстренной контрацепции

Country Status (9)

Country Link
US (1) US20090170823A1 (enExample)
EP (1) EP2234491A4 (enExample)
JP (2) JP2011507853A (enExample)
AU (1) AU2008341138A1 (enExample)
BR (1) BRPI0819571A2 (enExample)
CA (1) CA2710293A1 (enExample)
EA (1) EA201070715A1 (enExample)
IL (1) IL206465A0 (enExample)
WO (1) WO2009082478A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008079245A2 (en) * 2006-12-20 2008-07-03 Duramed Pharmaceuticals, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
FR2937862B1 (fr) * 2008-11-03 2010-11-19 Mohammed Ridha Chakroun Kit contraceptif
EP2381947A4 (en) 2008-12-23 2012-08-22 Quest Diagnostics Invest Inc MASS SPECTROMETRY ASSAY FOR STROGENIC COMPOUNDS
RU2542779C2 (ru) * 2009-04-14 2015-02-27 Лаборатуар Хра-Фарма Способ контрацепции, используемый по мере необходимости
EP3943079A1 (en) 2013-05-21 2022-01-26 Predictive Therapeutics, LLC Therapeutic and method of use

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
IE61236B1 (en) 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
ATE209189T1 (de) * 1992-07-01 2001-12-15 Ortho Pharma Corp 1-arylsulfonyl-3-phenyl-1,4,5,6- tetrahydropyridazinen
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption
US5633011A (en) * 1994-08-04 1997-05-27 Alza Corporation Progesterone replacement therapy
RO120606B1 (ro) * 1994-10-24 2006-05-30 Schering Aktiengesellschaft Utilizare a antagoniştilor competitivi de progesteron, pentru controlul fertilităţii
ZA9510926B (en) * 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
AU2558297A (en) * 1996-05-16 1997-12-05 Gynetics Inc. Emergency contraceptive kit
FR2772617B1 (fr) * 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
US6368625B1 (en) * 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
US6060078A (en) 1998-09-28 2000-05-09 Sae Han Pharm Co., Ltd. Chewable tablet and process for preparation thereof
US6667050B1 (en) * 1999-04-06 2003-12-23 Galen (Chemicals) Limited Chewable oral contraceptive
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6399593B1 (en) * 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
US6355648B1 (en) * 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
UA73119C2 (en) * 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
HU227198B1 (en) * 2001-11-27 2010-10-28 Richter Gedeon Nyrt Pharmaceutical composition for emergency contraception containing levonorgestrel
US20030158432A1 (en) * 2002-01-08 2003-08-21 Leonard Thomas W. Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex
PT1482925E (pt) * 2002-03-11 2007-04-30 Bayer Schering Pharma Ag 5-(2-hidroxi-3-'1-(3-trifluorometilfenil)-ciclopropil]-propionilamino-ftalida e compostos relacionados com actividade de modulação do receptor da progesterona para utilização no controlo de fertilidade e terapia de substituição hormonal
AU2003245637A1 (en) * 2002-06-25 2004-01-06 Wyeth Use of thio-oxindole derivatives in treatment of hormone-related conditions
EP1515725A4 (en) * 2002-06-25 2005-09-21 Wyeth Corp USE OF CYCLOTHIOCARBAMATE DERIVATIVES IN THE TREATMENT OF HORMONE-RELATED ILLNESSES
MXPA04012420A (es) * 2002-06-25 2005-04-19 Wyeth Corp Derivados de ciclotiocabamativa como moduladores de rp y uso de los mismos para tratamiento de trastornos de la piel.
JP2006504736A (ja) * 2002-10-11 2006-02-09 リガンド・ファーマシューティカルズ・インコーポレイテッド 選択的プロゲステロンレセプター調節化合物としての５−（１’，１’−シクロアルキル／アルケニル）メチリデン１，２−ジヒドロ−５Ｈ−クロメノ［３，４−ｆ］キノリン
WO2004035883A2 (en) * 2002-10-17 2004-04-29 Nexen Nano Tech Co., Ltd Fibrous nano-carbon and preparation method thereof
NZ544007A (en) * 2003-05-07 2009-05-31 Samyang Corp Highly plastic granules for making fast melting tablets
AR047398A1 (es) * 2003-11-24 2006-01-18 Wyeth Corp Acoplamiento cruzado carbono- carbono catalizado por metales de transicion sobre soportes solidos
WO2005055945A2 (en) * 2003-12-08 2005-06-23 Gel-Del Technologies, Inc. Mucoadhesive drug delivery devices and methods of making and using thereof
CN1672685A (zh) * 2004-03-26 2005-09-28 董可娟 一种新的避孕药物
US7399870B2 (en) * 2004-03-30 2008-07-15 Wyeth Synthesis of pyrrole-2-carbonitriles
BRPI0509159B1 (pt) * 2004-04-08 2014-08-26 Wyeth Llc Processo para preparar um composto de fenoxicicloalquila
CA2561014C (en) * 2004-04-08 2013-09-10 Wyeth Thioamide derivatives as progesterone receptor modulators
ATE409699T1 (de) * 2004-04-08 2008-10-15 Wyeth Corp Verfahren zur minimierung von thioamidverunreinigungen
AR049631A1 (es) * 2004-04-27 2006-08-23 Wyeth Corp Proceso de acoplamiento para la generacion de derivados reactivos de pirrol -2- carbonitrilo n- sustituidos con contenido de boro para producir biarilos
WO2005105739A2 (en) 2004-04-27 2005-11-10 Wyeth Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
CA2563063C (en) * 2004-04-27 2014-06-03 Wyeth Purification of progesterone receptor modulators
EP1773344A1 (en) 2004-07-07 2007-04-18 Wyeth a Corporation of the State of Delaware Cyclic progestin regimens and kits
GT200500183A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
DK1778710T3 (da) * 2004-08-13 2012-04-16 Wyeth Llc Tanaprogetderivater, -metabolitter og anvendelser deraf
JP2008510722A (ja) * 2004-08-20 2008-04-10 ワイス プロゲステロン受容体構造
JP4197684B2 (ja) * 2005-03-23 2008-12-17 株式会社東芝 携帯無線機
DK1874278T3 (da) 2005-04-28 2009-09-28 Wyeth Corp Sammensætninger indeholdende mikroniseret tanaproget
US7786297B2 (en) * 2005-04-28 2010-08-31 Wyeth Llc Purified form of tanaproget
ES2340610T3 (es) * 2005-04-28 2010-06-07 Wyeth Llc Composiciones de tanaproget micronizado y procedimientos de preparacion de las mismas.
CN101166736B (zh) * 2005-04-28 2013-02-06 惠氏公司 他那普戈特的多晶型ⅱ
JP5149160B2 (ja) * 2005-04-28 2013-02-20 ワイス・エルエルシー ミクロ化タナプロゲットおよびこれを含む組成物
CN101166722A (zh) * 2005-04-29 2008-04-23 惠氏公司 制备3,3-二取代的羟吲哚和硫代羟吲哚的方法
KR100733419B1 (ko) * 2005-04-30 2007-06-29 주식회사 하이닉스반도체 내부전원 생성장치
UY29527A1 (es) * 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
US20060293295A1 (en) * 2005-05-13 2006-12-28 Kai Strothmann Pharmaceutical composition comprising progestogens and/or estrogens and 5-methyl- (6S)-tetrahydrofolate
AU2006249349B2 (en) * 2005-05-26 2012-01-12 Teva Women's Health, Inc. Oral dosage forms comprising progesterone and methods of making and using the same
CN103989687A (zh) 2005-06-09 2014-08-20 惠氏公司 含有炔雌醇的tanaproget组合物
US20100105640A1 (en) * 2005-06-28 2010-04-29 Casper Robert F Aromatase Inhibitors for Emergency Contraception
PE20070404A1 (es) * 2005-07-29 2007-05-10 Wyeth Corp Compuestos derivados de cianopirrol-sulfonamida como moduladores del receptor de progesterona
PE20070341A1 (es) * 2005-07-29 2007-04-13 Wyeth Corp Derivados de pirrol como moduladores del receptor de progesterona
PE20070182A1 (es) * 2005-07-29 2007-03-06 Wyeth Corp Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona
AR056048A1 (es) * 2005-09-01 2007-09-12 Tanabe Seiyaku Co Compuesto tiomorfolina y procedimiento para preparar el mismo
US20070066628A1 (en) * 2005-09-19 2007-03-22 Wyeth 5-Aryl-indan-1-ol and analogs useful as progesterone receptor modulators
US7319152B2 (en) * 2005-09-19 2008-01-15 Wyeth 5-Aryl-indan-1-one and analogs useful as progesterone receptor modulators
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
US20070093548A1 (en) * 2005-10-25 2007-04-26 Wyeth Use of progesterone receptor modulators
US20070213526A1 (en) * 2006-03-07 2007-09-13 Wyeth Purification of progesterone receptor modulators
TW200810231A (en) * 2006-08-11 2008-02-16 Hon Hai Prec Ind Co Ltd Antenna device
WO2008079245A2 (en) * 2006-12-20 2008-07-03 Duramed Pharmaceuticals, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof

Also Published As

Publication number Publication date
JP2014193918A (ja) 2014-10-09
US20090170823A1 (en) 2009-07-02
JP2011507853A (ja) 2011-03-10
IL206465A0 (en) 2010-12-30
AU2008341138A1 (en) 2009-07-02
CA2710293A1 (en) 2009-07-02
BRPI0819571A2 (pt) 2019-09-24
WO2009082478A1 (en) 2009-07-02
EP2234491A1 (en) 2010-10-06
EP2234491A4 (en) 2010-12-22

Similar Documents

Publication Publication Date Title
UA108741C2 (uk) Фармацевтична композиція для екстреної контрацепції
ECSP10010439A (es) Antagonistas n,n-disustituidos de aminoalquilbifenilo de receptores d2 de prostaglandina
EA201391613A8 (ru) КОМПОЗИЦИЯ АНТИ-α4β7 АНТИТЕЛА
EA201290183A1 (ru) Бензодиазепиновый ингибитор бромодомена
ECSP13013050A (es) Formulación para anticuerpo anti- 4 7
EA201300146A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ МОДУЛЯТОРА c-МЕТ
EA201791328A1 (ru) Стабилизированные композиции, содержащие антитела к рецептору интерлейкина-4 (il-4r)
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
EA201590805A1 (ru) Композиция с немедленным и пролонгированным высвобождением
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
UA112549C2 (uk) Частинки на основі поліакрилату, що містять активну сполуку
IN2014DN09571A (enExample)
EA201070715A1 (ru) Режимы дозирования, фармацевтические композиции и упаковки для экстренной контрацепции
EA201492091A1 (ru) Фармацевтические композиции для местного применения, содержащие тербинафид и мочевину
CY1109537T1 (el) Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης
EA201100430A1 (ru) Стабильная комбинированная фармацевтическая композиция
TR201906685T4 (tr) Kristalin macitentan içeren farmasötik bileşim.
EA201300857A1 (ru) Пиразолы в качестве антагонистов crth2
UA115257C2 (uk) Фармацевтична композиція у формі твердої суміші, що містить кандесартану цилексетил та амлодипін
EA201171414A1 (ru) Ингибиторы белков семейства iap
EA201390950A1 (ru) Гомогенные фармацевтические пероральные лекарственные формы, содержащие лерканидипин и эналаприл или их фармацетически приемлемые соли совместно с органической кислотой
EA201691034A1 (ru) Композиции в твердой форме с замедленным высвобождением для перорального введения
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
FR2915993B1 (fr) Nouveaux ligands agonistes des recepteurs pars, utilisation en medecine humaine ainsi qu'en cosmetique.
MX2009005329A (es) Composiciones farmaceuticas anticonvulsivas.